The companies are a unique blend of talented researchers and aspiring companies all striving for innovation in their designated discipline.
While the Park is made up of many individual companies, it functions as a community with encouraged cooperative communication between the tenants.
InvivoSciences, Inc. (IVS) is a preclinical stage biotech company developing heart failure (HF) therapeutics using a precsion medicine approach that has been successful in oncology. InvivoSciences aims to produce therapes for cardiovascular diseases including heart failure with the debut of its pioneering, automated and AI integrated 3Dengineered human tissue discovery platform Nuheart. It combines mature cardiac organoids with a cutting-edge AI, multi-omics and data sciences-driven approach, uncovering novel therapeutic targets and assets to offer better efficacy and safety profiles in humans, to advance precision medicine for cardiology. IVS also developed an AI-Assisted, systems-biology integrated patient Stratification Technology (AASIST) platform that analyzes cardiovascular functional data collected routine diagnostic procedures.